Datasets:
PatSnap
/
patent-linked-siRNA

Dataset card Data Studio Files
xet
 Community
sequence
stringlengths
4
17.9k
seq_id
stringlengths
1
6
pn
stringclasses
996 values
title
stringclasses
871 values
pbdt
int64
20.2M
20.3M
status
int64
1
225
⌀
family_country
listlengths
1
55
modified_info
stringlengths
112
8.31k
⌀
ttgggtttctttagtttatga
3929
IL309897A
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
ttgggtttctttagtttatga
3391
IL309897A
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
ttgggtttctttagtttatga
3391
IL309897A
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
ttgggtttctttagtttatga
4738
IL309897A
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
ttgggtttctttagtttatga
4738
IL309897A
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
ttgggtttctttagtttatga
3929
IL309897A0
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
[{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O...
ttgggtttctttagtttatga
3929
IL309897A0
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
[{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O...
cagctatccatcagatgatct
5547
IL309897A
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
cagctatccatcagatgatct
5547
IL309897A
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
cagctatccatcagatgatct
7086
IL309897A0
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
[{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylcytidine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["cm"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-...
cagctatccatcagatgatct
7086
IL309897A0
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
[{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylcytidine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["cm"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-...
cagctatccatcagatgatct
5547
IL309897A0
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
cagctatccatcagatgatct
5547
IL309897A0
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
cagctatccatcagatgatct
7086
IL309897A
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
cagctatccatcagatgatct
7086
IL309897A
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
cagctatccatcagatgatct
6596
IL309897A
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
cagctatccatcagatgatct
6596
IL309897A
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
cagctatccatcagatgatct
6596
IL309897A0
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
[{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylcytidine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["cm"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-...
cagctatccatcagatgatct
6596
IL309897A0
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
[{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylcytidine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["cm"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-...
gttgggtaaatatgcttatta
979
IL309897A
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
gttgggtaaatatgcttatta
979
IL309897A
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
gttgggtaaatatgcttatta
979
IL309897A0
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
gttgggtaaatatgcttatta
979
IL309897A0
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
gttgggtaaatatgcttatta
1517
IL309897A0
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
[{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos...
gttgggtaaatatgcttatta
1517
IL309897A0
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
[{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos...
gttgggtaaatatgcttatta
1517
IL309897A
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
gttgggtaaatatgcttatta
1517
IL309897A
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
gttgggtaaatatgcttatta
2326
IL309897A
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
gttgggtaaatatgcttatta
2326
IL309897A
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
gttgggtaaatatgcttatta
2326
IL309897A0
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
[{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos...
gttgggtaaatatgcttatta
2326
IL309897A0
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
[{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos...
cctttttaagttagcaggacttt
2144
IL309897A
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
cctttttaagttagcaggacttt
2144
IL309897A
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
cctttttaagttagcaggacttt
2144
IL309897A0
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
cctttttaagttagcaggacttt
2144
IL309897A0
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
gcctgcttatgctgtagtctgcc
5484
IL309897A
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
gcctgcttatgctgtagtctgcc
5484
IL309897A
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
gcctgcttatgctgtagtctgcc
5484
IL309897A0
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
gcctgcttatgctgtagtctgcc
5484
IL309897A0
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
aagcttgtccaagatgcttctct
5265
IL309897A
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
aagcttgtccaagatgcttctct
5265
IL309897A
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
aagcttgtccaagatgcttctct
4995
IL309897A0
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
aagcttgtccaagatgcttctct
4995
IL309897A0
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
aagcttgtccaagatgcttctct
4995
IL309897A
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
aagcttgtccaagatgcttctct
4995
IL309897A
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
aagcttgtccaagatgcttctct
5265
IL309897A0
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
[{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI...
aagcttgtccaagatgcttctct
5265
IL309897A0
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
[{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI...
gaaattgccataagccatattac
4433
IL309897A
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
gaaattgccataagccatattac
4433
IL309897A
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
gaaattgccataagccatattac
4433
IL309897A0
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
gaaattgccataagccatattac
4433
IL309897A0
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
atggtccagcaggcttgaagt
7219
IL309897A0
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
[{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI...
atggtccagcaggcttgaagt
7219
IL309897A0
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
[{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI...
atggtccagcaggcttgaagt
5951
IL309897A0
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
atggtccagcaggcttgaagt
5951
IL309897A0
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
atggtccagcaggcttgaagt
7219
IL309897A
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
atggtccagcaggcttgaagt
7219
IL309897A
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
atggtccagcaggcttgaagt
5951
IL309897A
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
atggtccagcaggcttgaagt
5951
IL309897A
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
atggtccagcaggcttgaagt
7045
IL309897A0
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
[{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI...
atggtccagcaggcttgaagt
7045
IL309897A0
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
[{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI...
atggtccagcaggcttgaagt
7045
IL309897A
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
atggtccagcaggcttgaagt
7045
IL309897A
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
atgagttattctgggacgactgg
6082
IL309897A0
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
[{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]}],"locations":["2->2"],"infos":["OTHER"]},{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]}],"locations":["7->7"],"infos":["OTHER"]},{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]}],"loca...
atgagttattctgggacgactgg
6082
IL309897A0
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
[{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]}],"locations":["2->2"],"infos":["OTHER"]},{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]}],"locations":["7->7"],"infos":["OTHER"]},{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]}],"loca...
atgagttattctgggacgactgg
6479
IL309897A
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
atgagttattctgggacgactgg
6479
IL309897A
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
atgagttattctgggacgactgg
6479
IL309897A0
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
[{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]}],"locations":["7->7"],"infos":["OTHER"]}]
atgagttattctgggacgactgg
6479
IL309897A0
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
[{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]}],"locations":["7->7"],"infos":["OTHER"]}]
atgagttattctgggacgactgg
6082
IL309897A
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
atgagttattctgggacgactgg
6082
IL309897A
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
ggactgcactgcagcacctccac
5403
IL309897A0
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
ggactgcactgcagcacctccac
5403
IL309897A0
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
ggactgcactgcagcacctccac
5403
IL309897A
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
ggactgcactgcagcacctccac
5403
IL309897A
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
aagacggatgtgccagatatt
193
IL309897A0
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
aagacggatgtgccagatatt
193
IL309897A0
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
aagacggatgtgccagatatt
6925
IL309897A0
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
[{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI...
aagacggatgtgccagatatt
6925
IL309897A0
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
[{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI...
aagacggatgtgccagatatt
6925
IL309897A
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
aagacggatgtgccagatatt
6925
IL309897A
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
aagacggatgtgccagatatt
463
IL309897A0
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
[{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI...
aagacggatgtgccagatatt
463
IL309897A0
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
[{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI...
aagacggatgtgccagatatt
193
IL309897A
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
aagacggatgtgccagatatt
193
IL309897A
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
aagacggatgtgccagatatt
463
IL309897A
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
aagacggatgtgccagatatt
463
IL309897A
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
gctagccaagcagcaaatcct
7111
IL309897A0
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
[{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos...
gctagccaagcagcaaatcct
7111
IL309897A0
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
[{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos...
gctagccaagcagcaaatcct
5614
IL309897A0
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
gctagccaagcagcaaatcct
5614
IL309897A0
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
gctagccaagcagcaaatcct
6669
IL309897A0
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
[{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos...
gctagccaagcagcaaatcct
6669
IL309897A0
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
[{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos...
gctagccaagcagcaaatcct
5614
IL309897A
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
gctagccaagcagcaaatcct
5614
IL309897A
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
gctagccaagcagcaaatcct
7111
IL309897A
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
gctagccaagcagcaaatcct
7111
IL309897A
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
gctagccaagcagcaaatcct
6669
IL309897A
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
gctagccaagcagcaaatcct
6669
IL309897A
הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם
20,240,301
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
null
tacggttaagttaaataagagtt
1751
IL309897A0
Metabolic disorder-associated target gene irna compositions and methods of use thereof
20,240,201
101
[ "CN", "IN", "US", "WO", "JP", "NZ", "CL", "EP", "RU", "HK", "IL", "SG", "CA", "TW", "CO", "ZA", "SA", "AU", "MX", "AR", "BR", "KR" ]
[{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"Vinyl-phosphonate 2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"inf...